We are live on
!
Find out more
CCC
Chelsea Counsel Company Portfolio holdings
AUM
$236M
1-Year Est. Return
51.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.36%
1 Year Est. Return
+51.76%
3 Year Est. Return
+106.38%
5 Year Est. Return
+132.3%
10 Year Est. Return
+407.64%
AUM
$200M
AUM Growth
+$38.1M
(+23%)
Cap. Flow
+$25.8M
Cap. Flow
% of AUM
12.9%
Top 10 Holdings %
Top 10 Hldgs %
43.6%
Holding
173
New
92
Increased
14
Reduced
36
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$14.3M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$6.57M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.9M |
| 4 |
Quanta Services
PWR
|
+$3.21M |
| 5 |
General Mills
GIS
|
+$2.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$3.13M |
| 2 |
Costco
COST
|
+$965K |
| 3 |
Thermo Fisher Scientific
TMO
|
+$892K |
| 4 |
Ecolab
ECL
|
+$842K |
| 5 |
Microsoft
MSFT
|
+$680K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.93% |
| 2 | Healthcare | 13.63% |
| 3 | Industrials | 12.91% |
| 4 | Energy | 12.53% |
| 5 | Consumer Staples | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Rivian
RIVN
$23.3B
| $9.21K | ﹤0.01% |
+500
| New | +$14.7K |
|
152
Wells Fargo
WFC
$268B
| $5.99K | ﹤0.01% |
+145
| New | +$6.42K |
|
153
Accenture
ACN
$108B
| $5.34K | ﹤0.01% |
+20
| New | +$5.53K |
|
154
Kyndryl
KD
$2.76B
| $4.23K | ﹤0.01% |
+380
| New | +$3.82K |
|
155
Coherent
COHR
$68.2B
| $4.21K | ﹤0.01% |
+120
| New | +$4.17K |
|
156
Adobe
ADBE
$102B
| $3.37K | ﹤0.01% |
+10
| New | +$3.2K |
|
157
Bristol-Myers Squibb
BMY
$131B
| $2.52K | ﹤0.01% |
+35
| New | +$2.64K |
|
158
Uranium Energy
UEC
$5.71B
| $2.02K | ﹤0.01% |
+520
| New | +$1.97K |
|
159
GE Aerospace
GE
$379B
| $1.51K | ﹤0.01% |
+29
| New | +$1.43K |
|
160
Warner Bros
WBD
$69B
| $1.51K | ﹤0.01% |
+159
| New | +$1.79K |
|
161
Occidental Petroleum Corp Warrants
OXY.WS
$34.4B
| $495 | ﹤0.01% |
+12
| New | +$554 |
|
|
AVNS
162
DELISTED
Avanos Medical
AVNS
| $135 | ﹤0.01% |
+5
| New | +$122 |
|
|
163
3M
MMM
$93.9B
| – | – |
-33,885
| Closed | -$3.13M |
|
164
Sempra
SRE
$56.1B
| – | – |
-3,006
| Closed | -$225K |
|
165
Teck Resources
TECK
$33.1B
| – | – |
-6,650
| Closed | -$202K |
|
Similar funds
TCM
PVM
JRPCML
BCM
FCMI
CF
MC
BWM
Chelsea Counsel Company's Q4 2022 Portfolio in Review
As of Q4 2022, Chelsea Counsel Company held 173 positions worth $200M, up 23% from $162M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Chelsea Counsel Company deployed $25.8M of net new capital in Q4 2022, opening 92 new positions and adding to 14 existing holdings. Its largest new stake was Vanguard High Dividend Yield ETF: 134,800 shares worth $14.6M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Costco, an estimated $965K trimmed.
- Chelsea Counsel Company's largest Q4 2022 buy was Vanguard High Dividend Yield ETF: 134,800 shares worth $14.6M.
- Chelsea Counsel Company added most to Apple in Q4 2022, an estimated $744K increase.
- Chelsea Counsel Company's biggest Q4 2022 reduction was Costco, cutting an estimated $965K.
- Chelsea Counsel Company fully exited 3M in Q4 2022, selling an estimated $3.13M.
- Chelsea Counsel Company's ten largest holdings make up 44% of its $200M portfolio in Q4 2022.
- Chelsea Counsel Company opened 92 new positions and closed 11 in Q4 2022.
- Chelsea Counsel Company's portfolio value rose 23% quarter-over-quarter to $200M.
Based on Chelsea Counsel Company's 13F filing for Q4 2022, filed 23 Feb 2023.